Affiliation:
1. Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan,1 and
2. Laboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium2
Abstract
ABSTRACT
The recently described genus
Pandoraea
contains five named species (
Pandoraea apista
,
Pandoraea pulmonicola
,
Pandoraea pnomenusa
,
Pandoraea sputorum
, and
Pandoraea norimbergensis
) and four unnamed genomospecies.
Pandoraea
spp. have mainly been recovered from the respiratory tracts of cystic fibrosis (CF) patients. Accurate genus- and species-level identification by routine clinical microbiology methods is difficult, and differentiation from
Burkholderia cepacia
complex organisms may be especially problematic. This can have important consequences for the management of CF patients. On the basis of 16S ribosomal DNA sequences, PCR assays for the identification of
Pandoraea
spp. were developed. A first PCR assay was developed for the identification of
Pandoraea
isolates to the genus level. PCR assays for the identification of
P. apista
and
P. pulmonicola
as a group,
P. pnomenusa
,
P. sputorum
, and
P. norimbergensis
were also developed. All five assays were evaluated with a panel of 123 bacterial isolates that included 69
Pandoraea
sp. strains, 24
B. cepacia
complex strains, 6
Burkholderia gladioli
strains, 9
Ralstonia
sp. strains, 5
Alcaligenes xylosoxidans
strains, 5
Stenotrophomonas maltophilia
strains, and 5
Pseudomonas aeruginosa
strains. The use of these PCR assays facilitates the identification of
Pandoraea
spp. and avoids the misidentification of a
Pandoraea
sp. as a
B. cepacia
complex isolate.
Publisher
American Society for Microbiology
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献